The mutation spectrum revealed by paired genome sequences from a lung cancer patient W Lee, Z Jiang, J Liu, PM Haverty, Y Guan, J Stinson, P Yue, Y Zhang, ... Nature 465 (7297), 473-477, 2010 | 635 | 2010 |
Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin A Lai, S Kharbanda, WB Pope, A Tran, OE Solis, F Peale, WF Forrest, ... Journal of clinical oncology 29 (34), 4482-4490, 2011 | 542 | 2011 |
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection RM Lynch, E Boritz, EE Coates, A DeZure, P Madden, P Costner, ... Science translational medicine 7 (319), 319ra206-319ra206, 2015 | 475 | 2015 |
Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non–Small Cell Lung Cancers E Lin, L Li, Y Guan, R Soriano, CS Rivers, S Mohan, A Pandita, J Tang, ... Molecular Cancer Research 7 (9), 1466-1476, 2009 | 424 | 2009 |
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India A Patel, H Kaur, I Xess, JS Michael, J Savio, S Rudramurthy, R Singh, ... Clinical microbiology and infection 26 (7), 944. e9-944. e15, 2020 | 422 | 2020 |
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults Clinical & Experimental Immunology 182 (3), 289-301, 2015 | 279 | 2015 |
Structural basis for substrate selectivity in human maltase-glucoamylase and sucrase-isomaltase N-terminal domains L Sim, C Willemsma, S Mohan, HY Naim, BM Pinto, DR Rose Journal of Biological Chemistry 285 (23), 17763-17770, 2010 | 252 | 2010 |
New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from … L Sim, K Jayakanthan, S Mohan, R Nasi, BD Johnston, BM Pinto, ... Biochemistry 49 (3), 443-451, 2010 | 213 | 2010 |
Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models JM Spoerke, C O'Brien, L Huw, H Koeppen, J Fridlyand, RK Brachmann, ... Clinical cancer research 18 (24), 6771-6783, 2012 | 209 | 2012 |
High d (+) glucose concentration inhibits RANKL-induced osteoclastogenesis Y Wittrant, Y Gorin, K Woodruff, D Horn, HE Abboud, S Mohan, ... Bone 42 (6), 1122-1130, 2008 | 196 | 2008 |
COP1 is a tumour suppressor that causes degradation of ETS transcription factors AC Vitari, KG Leong, K Newton, C Yee, K O’Rourke, J Liu, L Phu, R Vij, ... Nature 474 (7351), 403-406, 2011 | 179 | 2011 |
The PI 3 K/A kt/m TOR axis in head and neck cancer: functions, aberrations, cross‐talk, and therapies R Vander Broek, S Mohan, DF Eytan, Z Chen, C Van Waes Oral diseases 21 (7), 815-825, 2015 | 176 | 2015 |
Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non–small cell lung cancer: MET expression levels are predictive of … H Koeppen, W Yu, J Zha, A Pandita, E Penuel, L Rangell, R Raja, ... Clinical Cancer Research 20 (17), 4488-4498, 2014 | 148 | 2014 |
Degradation of the S. frugiperda peritrophic matrix by an inducible maize cysteine protease S Mohan, PWK Ma, T Pechan, ER Bassford, WP Williams, DS Luthe Journal of Insect Physiology 52 (1), 21-28, 2006 | 142 | 2006 |
Zwitterionic glycosidase inhibitors: salacinol and related analogues S Mohan, BM Pinto Carbohydrate Research 342 (12-13), 1551-1580, 2007 | 135 | 2007 |
Impact of insecticides on sucking pests and natural enemy complex of transgenic cotton M Kannan, S Uthamasamy, S Mohan Current Science, 726-729, 2004 | 123 | 2004 |
Role of various flavonoids: Hypotheses on novel approach to treat diabetes S Mohan, L Nandhakumar Journal of Medical Hypotheses and Ideas 8 (1), 1-6, 2014 | 122 | 2014 |
Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer C O'Brien, G Cavet, A Pandita, X Hu, L Haydu, S Mohan, K Toy, CS Rivers, ... Cancer research 68 (13), 5380-5389, 2008 | 119 | 2008 |
Preliminary Immunomodulatory Activities of the Aqueous Extract of Terminalia chebula. HN Shivaprasad, MD Kharya, AC Rana, S Mohan Pharmaceutical Biology 44 (1), 32-34, 2006 | 119 | 2006 |
Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles S Mohan, S McAtamney, T Haselhorst, M von Itzstein, BM Pinto Journal of medicinal chemistry 53 (20), 7377-7391, 2010 | 109 | 2010 |